Induction of micronuclei by a new non-peptidic mimetic farnesyltransferase inhibitor RPR-115135: Role of gene mutations

Mutagenesis

Volumn 16, Issue 5, 2001, Pages 423-430

  Ottoboni, Cristina ^a   Crippa, Alessandra ^a   Falugi, Carla ^b   Russo, Patrizia ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P53; RPR 115135; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; BREAST EPITHELIUM; CALCULATION; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL MEMBRANE; CHICK EMBRYO; COLON CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYO; EPITHELIUM CELL; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSDUCTION; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE; MICRONUCLEUS; MOLECULAR CLONING; NONHUMAN; ONCOGENE; ONCOGENE C ERB; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE NEU; ONCOGENE RAS; PRIORITY JOURNAL; REGULATOR GENE; SPINAL CORD; TRANSGENE;

EID: 0034820811     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/16.5.423     Document Type: Article

References (40)

1. A Phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity
2. Farnesyltransferase blocks the farnesylation of CENP-E and CENP-F and alters the association of CENP-E with the microtubules
3. Induction of micronuclei in Chinese hamster ovary cells treated with Pt co-ordination compounds
4. The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas
5. Additive effects of c-erbB-2, c-Ha-ras and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells
6. Mammalian centromeres: DNA sequence, protein composition and role in cell cycle progression
7. The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells
8. Cells lacking CIP1/WAF1 genes exibit preferential sensitivity to cisplatin and nitrogen mustard
9. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment
10. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines
11. Anticancer drug targets: Growth factors and growth factors signaling
12. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics
13. Multivariate data analysis using D-optimal designs, partial least squares and response surface modelling: A directional approach for the analysis of farnesyltransferase inhibitors
14. Inhibition of Ras-targeted prenylation: Protein farnesyl transferase inhibitors revisited
15. Signal transduction from multiple Ras effectors
16. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption and ribonucleotide depletion
17. Enhanced sensitivity to 1-β-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumour cell lines harboring activated ras oncogenes
18. Ras farnesyltransferase. A new therapeutic target
19. Inhibition of Ras prenylation: A signaling target for novel anti-cancer drug design
20. Optical studies of the interactions of 4′-6-diamidino-2 phenylindole with DNA and metaphase chromosomes
21. p53: Only ARF the story
22. + phenotype
23. Interaction between Ras, beta-catenin and p53 pathways in human cancer
24. Differential expression and mutation of the ras family genes in human breast cancer
25. INK4A alleles in neoplasia
26. Induction of kinetochore positive and negative micronuclei in V79 cells by the alkylating agent diethylsulphate
27. Farnesyltransferase inhibitors: Targeting the molecular basis of cancer
28. Farnesyltransferase as a target for anticancer drug design
29. Cellular actions of a farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line system
30. Cellular effects of a new farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line model system HCT-116
31. Inhibition of Ras prenylation: A novel approach to cancer chemotherapy
32. The Pezcoller Lecture: Cancer cell cycles revisited
33. Correlations among p53, Her-2/neu and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: Evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas
34. Oncogenes and tumour suppressor genes: Therapeutic implications
35. Expression of cyclins D1 and E in human colon adenocarcinomas
36. bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells
37. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis
38. ARF gene transfer in human mesothelioma cells
39. Expression of ras proto-oncogenes: Regulation and implications in the development of human tumours
40. Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer